Daclizumab to Treat HIV-Infected Patients

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 26, 2004

Study Completion Date

December 28, 2007

Conditions

HIV Infections

Interventions

DRUG

Daclizumab

Trial Locations (1)

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00080431 - Daclizumab to Treat HIV-Infected Patients | Biotech Hunter | Biotech Hunter